Overview / Abstract: |
Credit Available Physicians — maximum of 1.5 AMA PRA Category 1 Credit(s)™ Target Audience This online educational activity is directed toward primary care physicians, gynecologists, gastroenterologists, nurse practitioners, physician assistants, and primary care physicians. Additional health care professionals who are involved in the care of patients with IBS-C/CIC will also be invited to participate. Program Overview Medical Crossfire®, one of PER®’s signature educational formats, is a video-based program in which a panel of distinguished experts engage in spirted discussions and debates on a particular clinical topic. In this activity, 4 key thought leaders explore the latest data regarding current and emerging therapeutic strategies for the management of irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). This lively discussion will help place new developments into clinical context to help you optimize care for your patients with these disorders. Learning Objectives Upon completion of this activity, participants should be better able to: Describe the epidemiology, pathophysiology, and burden of IBS-C and CIC |
Expiration |
Nov 30, 2021 |
Discipline(s) |
Nursing CNE, Physician CME |
Format |
Online |
Credits / Hours |
1.5 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE Darren M. Brenner, ND, FACG, AGAF Maia Kayal, MD ddd |
Sponsors / Supporters / Grant Providers |
Takeda Pharmaceuticals U.S.A., Inc. |
Keywords / Search Terms |
Relias LLC FREE CME., Relias LLC., IBS-C and CIC Free CE CME |